DVMSE Seeks Clinical Trial Partner for Phase III COVID-19 Trial

Promising Treatment Against Covid-19 Pandemic Shows Zero Side Effects

FORT LAUDERDALE, Fla., USA – November 30, 2020 /MarketersMedia/ —

Today, Disabled Veterans Medical Supplies and Equipment (DVMSE) announced they are seeking a clinical trials partner to join forces with them on a so-far encouraging, side-effect free cure for COVID-19. The chosen partner will work with DVMSE for Phase III of a sponsored clinical trial. There is a huge global initiative to find a cure for the COVID-19 pandemic. Many governments, pharmaceutical companies, healthcare professionals and hospitals are working night and day to find a safe and effective treatment against the virus.

The World Health Organization (WHO) releases daily reports that, as of yet, there is no approved treatment for COVID-19. However, DVMSE has been able to produce a treatment for the coronavirus which has now shown successful results in over 100 people during its Phase I and Phase II clinical trials. These first two phases were done in partnership with a scientist from the UN who continues to help people with COVID-19 in Europe.

According to a spokesperson for DVMSE, “We are a group of veterans who have submitted a request for an Emergency FDA number in July 2020 so that we can perform the third clinical trial. How can it be that the FDA is not seeing fit to allow a trial to proceed for a viable cure? Why will the FDA not provide an Emergency Trial start number? It makes little sense to us, but we are not giving up.”

The spokesperson added, “It’s certainly an urgent matter. Few would disagree with that assessment of the state of affairs. In the United States, Coronavirus cases exceed 5 million out of the present 19 million global coronavirus cases. The U.S. now confirms 251,000 deaths with more than 2.6 million have recovered. DVSME has been working diligently on a safe coronavirus cure. Global scientists, and health professionals at DVMSE have received a license to introduce the new, revolutionary treatment to the United States. However, importing this new cure to the US can happen only after Phase III of an ongoing clinical trial has been successfully achieved and concluded.”

The treatment from DVMSE comprises a reliable and tested combination of medications providing a “synergy effect.” The human immune system is prompted to fight the virus within 30 hours of introduction, resulting in the infected patients testing negative. It uses a promising physical therapy diagnosis modality. Patients showing an advanced stage of COVID-19 are treated every 6 hours. Following the introduction of the treatment the virus dies and the patient gradually gains full recovery within a maximum of 30 hours.

When DVMSE gets a green light for its COVID-19 treatment, and it is officially approved by the Food and Drug Administration (FDA) as a safe, practical and effective cure for coronavirus, the company will begin manufacture and distribution to the U.S. population. To reach this stage, DVMSE needs to partner with a university or treatment center to provide the third trial.

The impending availability of this new treatment for coronavirus is encouraging. It addresses the enormity of the COVID-19 death rate. The best result depends upon efficacy and availability. Confirmed FDA approval would assure the American people that there is hope. The DVSME and its partners will help stem the overwhelming pandemic that threatens to continue after the conclusion of the Phase III trials.

For more information go to https://dvmse.com/

END

###

Contact Info:
Name: Media Relations
Email: Send Email
Organization: Disabled Veterans Medical Supplies and Equipment
Website: https://dvmse.com/

Source URL: https://marketersmedia.com/dvmse-seeks-clinical-trial-partner-for-phase-iii-covid-19-trial/88987981

Source: MarketersMedia

Release ID: 88987981